HOWARD M. TEMIN died on 9 February 1994, at the age 59. He was awarded the Nobel Prize in 1975 for the discovery of a new mechanism of genome reproduction, called 'reverse transcription'. Transcription is the term used to identify the transfer of information from genes made of DNA to their messengers, which are made of RNA. The messengers then transfer the information to the proteins, which express the information of the genes. In reverse transcription, on the contrary, the information is transferred from RNA to DNA as part of a reproductive cycle. Howard Temin (and independently David Baltimore) discovered the new mechanism by studying a class of viruses that cause leukemias or cancer in a variety of animals.
that the RNA genes existing today in viruses are remnants of the primordial genes, and that reverse transcription is a remnant of a transition state in which DNA genes were made by copying RNA genes.
The discovery of reverse transcription was also important for another reason: it is not only used by the class of viruses studied by Howard, since then called 'retroviruses', but also by numerous types of semi-independent elements present in all genomes and included in the category of 'transposons'. It is thought that much of the DNA not constituting genes (which is 97% in humans) is made up of such elements or is the result of their activity. Reverse transcription may therefore play an important role in shaping the genomes of all species.
The discovery of reverse transcription has also considerable medical significance because it makes it possible to detect and quantify viruses important in human pathology, such as HIV, the retrovirus responsible for AIDS, by measuring the amount of the enzyme, the 'reverse transcriptase', released by infected cells. This approach, which is highly selective because the reverse transcriptase released from cells appears to be only of viral origin was crucial for the discovery of some important human retroviruses, such as HIV and leukemiainducing viruses. The enzyme is also important for the study of genes, by allowing the synthesis of DNAs homologous to cellular messengers RNAs (so called cDNAs), which are crucial in genetics and in biotechnology.
The route by which Howard arrived at the discovery of reverse transcription began in 1955, with his arrival at Caltech, where he joined my group in the Division of Biology as a graduate student. One of the major research interests at the Division of Biology at that time was the study of bacteriophages, viruses that grow in bacteria, which had been started by Max Delbriick. He considered these viruses to be a powerful tool for the study of genes, an idea that subsequent results confirmed. In that group Jean Weigle popularized the phenomenon of bacterial lysogeny, in which a bacteriophage enters a bacterium and persists there through many generations (almost indefinitely) without interfering with the growth of the cell; but occasionally a bacterium of the infected culture lyses, and releases bacteriophage identical to that used initially to infect the cells. Evidently, the genes of the virus persist for many generations in the infected cells; as an indication of their existence, they cause some characteristic change of the cells, described as 'conversion'. There were many discussions and exchanges of ideas, about the significance of the findings as they developed in laboratories throughout the world. The mysterious phenomenon of lysogeny was at the centre of everybody's attention. Within DelbrUck's group I had started a subgroup dedicated to the study of viruses that infect animal or human cells (called 'animal viruses'), with the bacteriophage model in mind. The main goal was to study these viruses in cultured cells rather then in animals or chicken embryos, as was then customary. My first task had been that of developing a precise method for assaying animal viruses, and I adapted the 'plaque method' used with bacteriophages. The virus I had used had the property of killing the cells it infected, and the assay was based on the ability of a single viral particle to produce a small spot of cell destruction (the plaque) containing a homogenous viral population, in a layer of cells growing at the bottom of a Petri dish. The method was valid not only for assay, but also for obtaining genetically pure viral strains. This success stimulated our investigators to extend the culture approach to viruses that do not kill the cells, but rather cause cancer in animals; for this reason Harry Rubin joined my group. Harry had worked with viruses that cause leukemias in chicken ('avian leukosis viruses', later shown to be retroviruses), and was interested in developing an assay for them.
Howard came to Caltech from Swarthmore, and had many Eastern mannerisms. He was tall, thin, with a big crop of black curly hair, was neatly dressed, really stylish compared to other Caltech students. He smiled a lot, said little, was not eager to add his comments to other people's pronouncements, but when he did so it was in full honesty. Later on he adapted to the California life style, but not permanently: toward the end of his stay he went home, and returned again with the Swarthmore look. He began by working with Harry on the development of a focal assay for a virus related to the avian leukosis virus, the Rous Sarcoma Virus of chicken, based on the already known ability of the virus to 'transform' chicken cells in culture, that is to confer on them characteristic features, similar to those of cancer cells. They succeeded, and developed a method based on the formation of 'foci' of transformed cells, equivalent to the plaques produced by cell-killing viruses. In this way a tumourforming virus could be studied exactly like the other cell-killing viruses.
Howard applied this method to the study of the biology of the Rous sarcoma virus (RSV), concentrating on its ability to transform cells, in partial collaboration with Boris Ephrussi who came from Paris to spend some time in the laboratory. Howard was guided in this task by the philosophy deriving from the study of bacterial lysogeny, which permeated the laboratory. He expressed this feeling in a popular review of his work written in 1960: '... our ideas about viruses have changed drastically in the last decade. This change was caused by work with viruses which infect bacteria. Recent work done here at Caltech [his own work] has indicated that cancer viruses by their presence cause a genetic change in the infected cells'. He made the important observation that there are two types of the RSV, which, upon infecting the cells, give rise to two different morphologies: one type makes the cells round, the other fusiform. The change from one type to the other was a rare, sudden event, and was permanent, because all descendants of the virus then generated the same morphology. These characteristics suggested that the shift from one type to the other was due to a hereditary change, a 'mutation' in a viral gene.
The availability of the two viral types allowed Howard to determine that a transformed cell contains less than two, on the average, viral genomes; in turn this suggested that 'the virus, in some structural sense, as well as in a functional sense [because the morphology of the transformed cells depends on the type of cell that is infected] becomes a part of the genome of the host cell ' (1960) . Subsequently (1963) Howard referred to this, so far hypothetical, state of the viral genome as 'provirus', stressing that it was a genetic concept, without implications about its molecular nature. This hypothesis reflects the strong influence of the results coming out of the lysogeny work, in which the viral genome incorporated into the cellular genome in the lysogenic bacteria is called the 'prophage'. The connection to lysogeny is also evidenced by the fact that Howard did not use the word 'transformation', which was in general use to describe the changes induced by the Rous virus in the cells, but the word 'conversion', which was used by the lysogeny workers.
Ultimately this way of thinking created a split within the Delbriick group, which became evident when Howard discussed his work for the Ph.D. thesis in front of his committee, of which both Delbriick and I were members. Howard expressed the opinion that there was an important similarity between the effect of bacteriophage in lysogeny and that of the Rous virus in transformation, a statement that reflected the thinking of my group. This statement, however, was not acceptable to Delbruck, who insisted that although the experimental work was very good, the connection between lysogeny and transformation had not been demonstrated. I was surprised, because it seemed essential that Howard should look beyond the immediate validity of his experimental data, to formulate a hypothesis on which to base the experiments to be done next. In fact, lysogeny has been a powerful model in the work with tumour viruses for a number of years after these discussions took place.
After obtaining his Ph.D. in 1959, Howard stayed another year at Caltech, and then he moved to the University of Wisconsin, where he spent the rest of his career and of his life. This is an almost unique situation in academia for a person of his calibre, which reveals one aspect of Howard's personality: that he valued his work more than the attraction of changing place to encounter new environments, or the attraction of high-sounding administrative jobs; that he did not want to disrupt the lives of his wife, Rayla Greenberg Temin (a Drosophila geneticist at the University of Wisconsin) and daughters Sarah and Miriam, and that he valued the constant and friendly environment in which he operated. That attitude is also demonstrated by his lack of participation in the biotechnology industry, to which essentially all distinguished biologists of his age belong.
At Wisconsin Howard continued the search for the provirus, which became the grail of his scientific life. He made two important observations. One was the existence of cells transformed by the Rous virus that did not produce virus, a finding that reinforced the analogy of transformation to lysogeny; the other finding was of much wider significance and opened a completely new scenario. Under the assumption that the postulated provirus was made up of RNA (as are the genes of the virus), Howard tried to isolate the proviral RNA by blocking the production of cellular RNAs, that is the messengers corresponding to the DNA genes of the cell using a drug capable of doing so, Actinomycin D. To his surprise, the drug had the opposite effect: it blocked viral replication. This was a strong implication that there was a DNA intermediate in the replication of the RNA virus. The pursuit of this observation using a variety of drugs revealed a surprising regularity: all drugs capable of blocking DNA transcription interfered with the production of virus in previously infected cells; those capable of blocking DNA replication interfered with the establishment of infection but not with the production of virus after the cell was infected. Both results implicated DNA in the constitution of the provirus, and this implication was confirmed by hybridization experiments supporting the presence, in the infected or transformed cells, but not in normal cells, of DNA sequences homologous to those of the viral RNA. Howard wrote: 'The results presented here, taken together signify that the virus acts as a carcinogenic agent by adding some new information to the cells'. And after subsequent experiments confirmed the initial hybridization results he stated that 'the simplest hypothesis to explain these data is that the provirus of Rous sarcoma virus is a region of DNA homology with viral RNA stably integrated into the molecules of cellular DNA in the nucleus'. This was in agreement with the proposal of Alan Campbell (1962) that in bacterial lysogeny the prophage became inserted in the bacterial chromosome. In this way the provirus had acquired also a structural aspect. The presence of sequences homologous to the viral RNA in the DNA of the transformed cells was confirmed by other investigators but its significance was not universally accepted. This was because the effect was weak, due to the interference created by integrated retroviral genomes of evolutionary origin, the presence of which was unknown at that time. All his critics were looking only at the result of a single experiment, not at the whole picture, as Howard did. In the present age of extreme specialization this is an important warning.
Howard began developing a theory of the provirus. The theory assigned to the provirus the main role in carcinogenicity, as resulting from errors during the information transfer cycle from integrated DNA to RNA to free DNA to integrated DNA, which he postulated to occur not only in virus infected cells but also in normal cells, where it would be responsible for genetic changes during differentiation. He proposed that chemicals and other non-viral carcinogens would act by altering the genes of this system of information transfer. In this way he viewed carcinogenesis as an altered form of differentiation; variation occurring during the information transfer would be part of the mechanisms of both tumourigenesis and differentiation.
The research that produced the new findings marked a sharp departure from Howard's previous work. Although this research was connected with the line of thought inspired by the lysogeny model, it was not directly suggested by it; rather, it originated from the curiosity of a true investigator faced with an unknown entity, the provirus, balanced between the world of RNA (the genes of the virus) and that of DNA (the genes of the cell). He wanted to know: what is the provirus? And the answer he got raised an even bigger question: How is the DNA provirus made? The question remained unanswered for several years. It was continuously on Howard's mind, and he tried to answer it by searching for an enzyme capable of copying RNA into DNA in the infected cells. These attempts failed because the enzyme, if present, would have been very diluted and its properties being unknown, it would not be easily detectable. During these years Howard occupied himself studying the characteristics of the transformed cells.
But in the meantime new important developments were taking place. Investigators studying some cell-killing viruses discovered that enzymes essential for viral replication were carried in the viral particles themselves, so as to be available as soon as an infecting particle released its contents into a cell. At the same time a postdoc in Howard's lab, Satoshi Mizutani, showed that no new protein had to be made to permit the formation of the proviral DNA during Rous Sarcoma Virus infection; this finding suggested that the needed enzyme was already present. The two types of information together prompted them to look for the enzyme in the viral particles themselves, where they found it. Because the enzyme in the particles was present in high concentration and in a relatively pure state, it could be reliably detected. So the long sought enzyme was discovered in 1970 by Mizutani and Temin, and simultaneously by David Baltimore, who was working with another retrovirus. Howard named the enzyme 'RNA-dependent DNA polymerase' a name to be soon replaced in common parlance by that of 'reverse transcriptase', which Howard did not like because of its ambiguity.
This fundamental discovery opened up a new field of research, dealing with the nature of the enzyme and the process by which it achieves its goal. After receiving the Nobel Prize in 1975, Howard worked hard at answering these questions, and also at determining the general role of the provirus in carcinogenesis. For studying the enzyme he adopted a new virus, the 'Spleen necrosis virus', a cell-killing retrovirus, that was more suitable. He addressed several main topics: how the viral genome becomes integrated into the cellular DNA, the occurrence of recombination during reverse transcription, the development of vectors based on retroviruses for transferring genes, and the relationship of retroviruses to transposable elements. Many other laboratories took up some of these questions.
Howard and his associates made major contributions toward understanding the mechanism of integration, a very complicated process. They found that the first product of reverse transcription of the viral RNA appears in the cell cytoplasm as a linear DNA genome terminated at each end by two identical segments called LTRs (long terminal repeats). Later the same DNA appears in the nucleus accompanied by a new form, a circular molecule created by joining together the two ends of the LTRs, which therefore has the two LTRs attached to each other in tandem. This form then becomes integrated into the cellular DNA by a complex exchange. Howard showed that crucial for the integration is the short DNA sequence created by the joining of the LTRs, which he defined as the att (attachment) site, adopting the terminology used for designating a site with a similar role in bacterial lysogeny.
The examination of the integrated provirus revealed an interesting feature: that it is flanked by two identical short sequences of the cellular DNA. Howard noticed the similarity of this structure with those formed by movable elements (transposons), which are present in the genomes of many invertebrates, Some of these, such as the copia elements of Drosophila, seed themselves to other parts of the host genome by the cycle: transcriptionretrotranscription -integration, just like the retroviruses. In fact this relatedness, which Howard had already pointed out already in 1970, motivated him to carry out the experiments to explain how integration takes place. The similarity of the provirus to transposons suggested to him the hypothesis that retroviruses are evolutionarily derived from transposons, detailing the pathway through which this could have happened. This interest in broad questions emerging from his experimental work, and their intense pursuit is characteristic of Howard, and is shown by other examples.
All the work on integration required the determination of the role of small segments of the viral genome, and for doing so it became necessary to develop an adequate technology, based on DNA recombination. This need prompted Howard to develop a new type of vector for introducing recombinant DNA into cells, based on retroviruses, using the spleen necrosis virus with which he was familiar. His attempt was promoted by the knowledge that in highly oncogenic retroviruses the remnants of a cellular gene replace part of the viral genes needed for specifying viral proteins, without affecting the sites needed for forming a viral particle (such as the attachment site). These viruses are therefore 'defective', that is cannot replicate, except in cells containing a provirus able to generate the missing proteins to act as 'helper'; when these proteins are present, the defective virus can form viral particles. To produce a vector, Howard cloned the provirus derived from the infected cells, removed from it part of the genes for viral proteins, and replaced it with foreign DNA. The modified provirus was introduced into cells carrying the helper provirus capable of expressing the viral proteins, but lacking a site needed for entering a viral particle. This led to the formation of viral particles carrying the foreign DNA in the defective viral genome, surrounded by proteins provided by the helper. By demonstrating the functionality in the cells receiving the vector of the genes present in the foreign DNA, Howard opened the field of gene therapy, on which are presently based many hopes for the control of genetic diseases and cancer.
The successful development of such a vector in 1981 allowed, in subsequent years, the study of variation of retroviruses, that is, mutations occurring at a high rate during replication. Howard made many important contributions in this field.
Howard also made important contributions to understanding the main mechanism by which retroviruses can induce cancer or leukemias, that is, the incorporation of cellular genes into the viral genome, and their consequent deregulation, so that they become 'oncogenes'. He discovered a new oncogene ( v . r e l) , which is present in the reti highly oncogenic avian retrovirus, and showed that it can alter the transcription of cellular genes, a property that was later recognized in many other oncogenes. Rel, in fact, is the prototype of a family of genes that specify several important transcription factors. In another contribution to the oncogene field, he showed how a cellular gene could be incorporated into a viral genome by an exchange between the viral genome undergoing reverse transcription and a messenger of the cellular gene, through a type of recombination he had discovered.
After the AIDS epidemic began. Howard felt that his expertise in retrovirus biology should be brought to bear on this enormous problem of retroviral origin. When doubts were expressed about the viral origin of the disease, he joined others in supporting it openly. He made an interesting proposal for a new approach to a preventive vaccine against the AIDS virus (HIV) based on the differences between this virus and other retroviruses. HIV belongs to a group of retroviruses, called 'lentiviruses', which have a much more complex genome then regular retroviruses, including the addition of several genes. He was struck by the observation that whereas simple retroviruses are very abundant and well tolerated in lower animal species (e.g. chicken, mice), lentiviruses are present in primates and some large mammals (horses, bovines), in which they produce disease; and the disease arises because the host's defences are low or easily overcome, and, furthermore, when they exist they are defeated by the extreme variation of the viruses. He attributed the different outcomes of infection with the two types of virus to the additional genes present in lentiviruses, and proposed that an HIV vaccine should be made using a simplified HIV genome, from which all the extra genes are removed. Such a live vaccine would allow better host defences and, moreover, would be capable of protecting against all variants that HIV continuously produces, because it would itself undergo the same variation. To show the feasibility of the idea, he constructed a similar vaccine for a bovine lentivirus, the Bovine Leukemia virus.
Howard was a very creative, objective and strict experimental scientist, of absolute integrity, who produced extremely valuable work, but was also interested in broader questions. We have seen that he used the results of his work to feed his imagination and produce original theories of viral biology carcinogenesis or cellular differentiation. He was also very much concerned with the human side of the problems in which his work engaged him. He often wrote about the possible repercussions of his research on the cancer problem in general, and had a militant approach toward the use of tobacco, as one of the major unnecessary causes of cancer. I remember that during the week dedicated to the award of the Nobel Prize in Stockholm, Howard, David Baltimore and I had to participate in a press conference. As we entered the room, we were confronted with a large, elegant table, on which rested several massive brass ashtrays. As soon as Howard saw them, he asked in a loud voice that they be removed, pointing out that their presence was offensive to the three investigators, who had spent their lives in the fight against cancer. The ashtrays were promptly removed, and the press conference could get under way. It is ironic, and very sad, that Howard should die of lung cancer, which is caused in a large majority of cases, by tobacco smoke.
During all his life, Howard was a very dedicated teacher, and raised many disciples, who now occupy important positions in Academia or industry. He also participated very actively in the administration of science, especially as a member of the National Cancer Advisory Board. In that capacity he was a strong supporter of objectivity in the evaluation of the results of the work on the basis of which the grant awards are made. He had complete confidence in investigator-initiated research, at a time when political influences tended to weaken it; his own career was a clear proof of the value of individuality in pursuing scientific problems.
Howard was also very sensitive to some social policies of the U.S. government, and very outspokenly opposed to them. Again during the Stockholm week, it is customary that one of the Laureates of each discipline make a brief statement during the Royal dinner. I, being the oldest of my group, was asked to do so, but Howard said he should be allowed to do it, because he had something very important to say. So he did. The gist of his contribution was that the U.S. government was doing something very useful for mankind in its support of cancer research, but was to be criticized for the waste and human suffering it caused with the Vietnam war.
Howard made reference to social problems occasionally but forcefully in his scientific writings. For instance, in 1972 he wrote an article: 'The RNA Tumour Viruses -Background and Foreground', which concluded with the following statement:
We have been discussing the status of the scientific study o f RNA tumour viruses. It is clear that much more work can be done and needs to be done before we understand the replication o f these viruses and their relationship to human neoplasia. Now, we should also ask the question whether there should be an expansion o f cancer research. I think the answer to this question depends upon the source of the money to support this expansion. If this money is taken from the defence budget, fine. An expansion of cancer research which causes a diminution o f the money spent on defence would be a double benefit to our society. However, if the money for an expansion o f cancer research comes at the expense of the vast social needs that are tearing our society apart, I oppose an expansion o f cancer research. Other problems of our society, I feel, are more important at present. Even in the field of biological research, work on pollution of the biosphere and on population control is more important than expansion of cancer research.
Howard M. Temin will be remembered as a scientist who made a fundamental discovery by logically developing existing knowledge, raising new questions and devising new ways for answering them with imagination unfettered by conventional wisdom. By those who had the fortune of knowing him personally, he will be remembered as a gentle person, attached to his family, with a ready smile on his face, who looked at the positive side of things and had faith in the future. But he will also he remembered as a person with strong ideas in both scientific and social issues, who made them known without ambiguity when he felt it necessary. 
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